Related Experiment Video
Updated: Sep 12, 2025

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Racial and Sex Disparities in US Kidney Transplant Clinical Trials: A Comparative Analysis With National Transplant
Inbar Hazan1, Rahim Hirani1, Shreeya Agrawal1
1School of Medicine, New York Medical College, Valhalla, New York.
Introduction:
Chronic kidney disease and kidney failure disproportionately affect racial and ethnic minorities in the United States, yet these populations remain underrepresented in clinical trials, especially in kidney transplantation research. The objective of this study was to analyze the representation of racial, ethnic, and sex groups in US-based kidney transplant clinical trials and assess whether participant demographics reflect the population receiving transplants, using national registry data.
Methods:
A total of 188 completed interventional trials related to kidney transplantation (1995-2022) were extracted from clinicaltrials.gov. Demographic data-including race, ethnicity, and sex-were compared against national data from the Organ Procurement and Transplantation Network. Chi-square tests and logistic regressions were performed to assess representation trends and predictors of demographic data reporting.
Results:
Only 58.51% of trials reported race or ethnicity (P < 0.01). White participants were consistently overrepresented across all time periods, while Black, Asian, multiracial, and Indigenous participants were underrepresented, despite elevated disease burdens (P < 0.0001). From 2011 to 2015 to 2016-2020, Black representation increased significantly (P < 0.001), though still fell short of parity. Multiracial and Asian participants remain markedly underrepresented. Trials with pharmaceutical sponsorship were significantly less likely to report racial or ethnic data (P = 0.008). Females were also underrepresented, comprising only 35.88% of trial participants (P < 0.0001).
Conclusions:
The persistent underrepresentation of minority groups and females in kidney transplant trials undermines the generalizability of findings and perpetuates inequities in care. Comprehensive and intersectional demographic reporting should be mandated, and recruitment strategies must prioritize inclusivity to ensure that clinical research equitably serves all affected populations.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

